• Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: China

Fortune SGAM Pharmaceutical and Bios Selection Fund

+ Add to Watchlist

FSPHBIS:CH

1.23 CNY -0.00-0.24%

As of 21:19:06 ET on 04/17/2014.

Snapshot for Fortune SGAM Pharmaceutical and Bios Selection Fund (FSPHBIS)

Year To Date: +2.51% 3-Month: +0.41% 3-Year: - 52-Week Range: 1.14 - 1.60
1-Month: -4.96% 1-Year: -3.31% 5-Year: - Beta vs : -

Mutual Fund Chart for FSPHBIS

No chart data available.
  • FSPHBIS:CH 1.23
  • 1M
  • 1Y
Interactive FSPHBIS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FSPHBIS

Fortune SGAM Pharmaceutical and Bios Selection Fund is an open-ended fund incorporated in China. The Fund seeks to achieve long-term stable return via controlling risk and liquidity. The Fund invests at least 80% of its total equity investments into pharmaceutical and bios companies listed in China.

Inception Date: 03-02-2012 Telephone: 86-21-38505888 Tel
Managers: FAN HONG-BING / WANG ZHI-WEI
Web Site: www.fsfund.com

Fundamentals for FSPHBIS

NAV (on 2014-04-17) 1.23
Assets (M) (on 2013-12-31) 845.82
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 1,000.00

Dividends for FSPHBIS

No dividends reported

Fees & Expenses for FSPHBIS

Front Load 1.50
Back Load 1.50
Current Mgmt Fee 1.50
Redemption Fee 1.50
12b1 Fee -
Expense Ratio -

Top Fund Holdings for FSPHBIS

Filing Date: 12/31/2013
Name Position Value % of Total
Xiangxue Pharmaceutical Co Ltd 3,565,298 66,314,543 7.890%
Sinocare Inc 840,940 57,907,128 6.890%
Yunnan Baiyao Group Co Ltd 401,409 40,939,704 4.870%
Jiangsu Hengrui Medicine Co Lt 1,076,196 40,873,924 4.870%
China National Accord Medicine 745,465 34,515,030 4.110%
Aier Eye Hospital Group Co Ltd 1,061,703 33,135,751 3.940%
Shanghai Tofflon Science & Tec 907,988 30,989,630 3.690%
Shanghai Fosun Pharmaceutical 1,345,375 26,355,896 3.140%
Humanwell Healthcare Group Co 868,748 24,629,006 2.930%
Guizhou Yibai Pharmaceutical C 745,724 24,325,517 2.900%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil